Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558 | ISIN: INE794A01010 | Industry: Pharmaceuticals
| Expensive Performer
14000.0000 -326.00 (-2.28%)
NSE Jan 19, 2026 09:07 AM
Volume: 302
 

14000.00
-2.28%
BP Wealth
Neuland lab (NLL) has posted revenue of INR2,414mn with a 29.6% YoY increase, which was 12% below our estimate of INR 2,160mn. The revenue growth was mainly driven by strong traction in the CMS (54.6% YoY growth) segment, led by 33 molecules (Development + Commercialize) along with...
Number of FII/FPI investors increased from 248 to 257 in Dec 2025 qtr.
More from Neuland Laboratories Ltd.
Recommended